Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apisal is a brand of sterile, physiological saline (sodium chloride) nasal spray and drops developed and manufactured by Amman Pharmaceutical Industries. It is formulated as an isotonic or physiological solution (typically 0.74% or 0.9% sodium chloride) designed to moisturize dry nasal passages, cleanse the nasal cavity of allergens and irritants, and loosen thick mucus to relieve nasal congestion. It is safe for use across all age groups, including newborns, infants, and adults, and is commonly used for daily nasal hygiene, seasonal allergic rhinitis, and sinusitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride (Amman Pharmaceutical Industries).